Substitute prescribing involves the prescription in a controlled environment of a pharmaceutically manufactured medication to replace illicit or harmful drug use, as part of a broader package of psychosocial interventions to minimise withdrawal symptoms and assist an individual to gradually reduce drug misuse and/or the harms associated with high-risk using.
Get full access to this article
View all access options for this article.
References
1.
Booker M (2012a) The primary care management of substance misusers. InnovAiT5(7): 384–392. DOI: 10.1093/invait/ins103.
2.
Booker M (2012b) The assessment of substance misusers. InnovAiT5(7): 375–383. DOI: 10.1093/innovait/ins069.
NICE (2007) NICE Technology appraisal guidance 114: Methadone and buprenorphine for the management of opioid dependence. Available at: www.nice.org.uk/guidance/ta114 (accessed 4 January 2019).
Strang J, Hall W, Hickman M, et al. (2010) Impact of supervision of methadone consumption on deaths related to methadone overdose (1993-2008): Analyses using OD4 index in England and Scotland. BMJ 341: c4851. DOI: 10.1136/bmj.c4851.